Primary Record
AC1OCFA8
- In stock
- 550 g
- Purity
- 98.1 %
Compound Identifiers & Properties
- PubChem CID
- 135413531
- SMILES
- CC1=C(C2=NC1=CC3=NC(=CC4=C(C(C(=CC5=NC(=C2)C(=C5C)CCC(=O)N[C@@H](CC(=O)O)C(=O)O)N4)(C)O)/C=C/NO)C(=C3C=C)C)CCC(=O)N[C@@H](CC(=O)O)C(=O)O
- Canonical SMILES
- C=CC1=C(C)C2=CC3=C(/C=C/NO)C(C)(O)C(=CC4=NC(=CC5=NC(=CC1=N2)C(C)=C5CCC(=O)N[C@@H](CC(=O)O)C(=O)O)C(CCC(=O)N[C@@H](CC(=O)O)C(=O)O)=C4C)N3
Names & Synonyms
- AC1OCFA8
- ATX-S10
- ATX-S10 Na
- D07ZHM
- ATX-S10 Na(II)
- ATX-S-10
- Photodynamic therapy (cancer, AMD)
- CID6918318
- CID 6918318
- Photodynamic therapy, Allergan/Hamamatsu
- J645.150K
- Photodynamic therapy, Allergan/Photochemical
- Photodynamic therapy (cancer, AMD), Photochemical
- (2S)-2-[3-[(5Z,10Z,14Z,19Z)-18-[3-[[(2S)-1,4-dihydroxy-1,4-dioxobutan-2-yl]amino]-3-oxopropyl]-13-ethenyl-7-hydroxy-3,7,12,17-tetramethyl-8-[(E)-2-nitrosoethenyl]-22,23-dihydro-21H-porphyrin-2-yl]propanoylamino]butanedioic acid
- (2S)-2-{3-[20-(2-{[(1S)-1,2-dicarboxyethyl]carbamoyl}ethyl)-9-ethenyl-15-hydroxy-14-[2-(hydroxyimino)ethylidene]-5,10,15,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3(24),4,6,8,10,12,16(22),17,19-decaen-4-yl]propanamido}butanedioic acid
- N,N -[[3,7,12,17-Tetramethyl-13-ethenyl-7-hydroxy-8-[2-(hydroxyimino)ethylidene]-7,8-dihydro-21H,23H-porphyrin]-2,18-diylbis(1-oxo-3,1-propanediyl)]bis(L-aspartic acid)
- N,N -Bis[(S)-1,2-dicarboxyethyl]-3,7,12,17-tetramethyl-13-ethenyl-7-hydroxy-8-[2-(hydroxyimino)ethylidene]-7,8-dihydro-21H,23H-porphyrin-2,18-bispropanamide